To further validate these effects on LDs, we generated PC3LN4 prostate cancer cells lacking PIM1 (PC3LN4crisprPIM1) or stably overexpressing PIM1 (PC3LN4hPIM1) (Fig. 1E). Here, PIM1 is linked to prostate carcinoma.